Article Detail - JD DME
April 2024 HCPCS Updates - Revised
CMS has released the April 2024 Healthcare Common Procedure Coding System (HCPCS) File. Inclusion on this list does not indicate coverage. All HCPCS code changes are effective and should be used for claims with dates of service on or after April 1, 2024. Please watch the Noridian website for additional policy updates regarding HCPCS codes.
Added HCPCS Codes
Effective for dates of service on and after April 1, 2024
| HCPCS | DESCRIPTION |
|---|---|
| A4271 | Integrated lancing and blood sample testing cartridges for home blood glucose monitor, per month |
| A4593 | Neuromodulation stimulator system, adjunct to rehabilitation therapy regime |
| A4594 | Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each |
| E0152 | Walker, battery powered, wheeled, folding, adjustable or fixed height |
| E0468 | Home ventilator, dual-function respiratory device, also performs additional function of cough stimulation, includes all accessories, components and supplies for all functions |
| E0736 | Transcutaneous tibial nerve stimulator |
| E0738 | Upper extremity rehabilitation system providing active assistance to facilitate muscle re-education, include microprocessor, all components and accessories |
| E0739 | Rehab system with interactive interface providing active assistance in rehabilitation therapy, includes all components and accessories, motors, microprocessors, sensors |
| E2104 | Home blood glucose monitor for use with integrated lancing/blood sample testing cartridge |
| E2298 | Complex rehabilitative power wheelchair accessory, power seat elevation system, any type |
| J0177 | Injection, aflibercept hd, 1 mg |
| J0209 | Injection, sodium thiosulfate (hope), 100 mg |
| J0589 | Injection, daxibotulinumtoxina-lanm, 1 unit |
| J0650 | Injection, levothyroxine sodium, not otherwise specified, 10 mcg |
| J0651 | Injection, levothyroxine sodium (fresenius kabi) not therapeutically equivalent to j0650, 10 mcg |
| J0652 | Injection, levothyroxine sodium (hikma) not therapeutically equivalent to j0650, 10 mcg |
| J1203 | Injection, cipaglucosidase alfa-atga, 5 mg |
| J1323 | Injection, elranatamab-bcmm, 1 mg |
| J1434 | Injection, fosaprepitant (focinvez), 1 mg |
| J2277 | Injection, motixafortide, 0.25 mg |
| J2782 | Injection, avacincaptad pegol, 0.1 mg |
| J2801 | Injection, risperidone (rykindo), 0.5 mg |
| J3055 | Injection, talquetamab-tgvs, 0.25 mg |
| J3424 | Injection, hydroxocobalamin, intravenous, 25 mg |
| J7165 | Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity |
| J9376 | Injection, pozelimab-bbfg, 1 mg |
| K1037 | Docking station for use with oral device/appliance used to reduce upper airway collapsibility |
| L1320 | Thoracic, pectus carinatum orthosis, sternal compression, rigid circumferential frame with anterior and posterior rigid pads, custom fabricated |
| L5783 | Addition to lower extremity, user adjustable, mechanical, residual limb volume management system |
| L5841 | Addition, endoskeletal knee-shin system, polycentric, pneumatic swing, and stance phase control |
| Q5133 | Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg |
| Q5134 | Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg |
Deleted HCPCS Code
Invalid for billing for dates of service April 1, 2024 and after
| HCPCS | DESCRIPTION |
|---|---|
| E2300 | WHEELCHAIR ACCESSORY, POWER SEAT ELEVATION SYSTEM, ANY TYPE |
| J0576 | INJECTION, BUPRENORPHINE EXTENDED-RELEASE (BRIXADI), 1 MG |
| J1020 | INJECTION, METHYLPREDNISOLONE ACETATE, 20 MG |
| J1030 | INJECTION, METHYLPREDNISOLONE ACETATE, 40 MG |
| J1040 | INJECTION, METHYLPREDNISOLONE ACETATE, 80 MG |
| J1246 | INJECTION, DINUTUXIMAB, 0.1 MG |
| J1840 | INJECTION, KANAMYCIN SULFATE, UP TO 500 MG |
| J1850 | INJECTION, KANAMYCIN SULFATE, UP TO 75 MG |
| J2920 | INJECTION, METHYLPREDNISOLONE SODIUM SUCCINATE, UP TO 40 MG |
| J2930 | INJECTION, METHYLPREDNISOLONE SODIUM SUCCINATE, UP TO 125 MG |
| J9070 | CYCLOPHOSPHAMIDE, 100 MG |
| J9250 | METHOTREXATE SODIUM, 5 MG |
Description Update
The long description of the HCPCS code has been updated as of April 1, 2024
| HCPCS | DESCRIPTION |
|---|---|
| E2001 | Suction pump, home model, portable or stationary, electric, any type, for use with external urine and/or fecal management system |
| J0208 | Injection, sodium thiosulfate (pedmark), 100 mg |
| J0612 | Injection, calcium gluconate, not otherwise specified, 10 mg |
| J0613 | Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg |
| J3380 | Injection, vedolizumab, intravenous, 1 mg |
| J3425 | Injection, hydroxocobalamin, intramuscular, 10 mcg |
| J7516 | Injection, cyclosporine, 250 mg |
| J9029 | Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose |
| J9260 | Injection, methotrexate sodium, 50 mg |
| J9071 | Injection, cyclophosphamide (auromedics), 5 mg |
| J9072 | Injection, cyclophosphamide (dr. reddy's), 5 mg |
Last Updated Mar 15 , 2024
